Overview

Clinical Trial Phase III to Assess the Non-inferiority of Dalap Duo® Product Compared to Epiduo® in the Treatment of Acne Vulgaris

Status:
Withdrawn

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

This study evaluates the non-inferiority of the product Dalap Duo® compared to Epiduo® medicine to treat acne. Half of the participants will receive Dalap Duo®, while the other half will receive Epiduo®.

Phase:

Phase 3

Details

Lead Sponsor:

Ache Laboratorios Farmaceuticos S.A.

Treatments:

Adapalene
Adapalene, Benzoyl Peroxide Drug Combination
Benzoyl Peroxide